High throughput screening in calcium transient assay to assess cardiotoxicity of compounds using hiPSC-derived cardiomyocytes

Farbod Famili, Tsang WaiLam, Pieter van Loenen, Peter Nacken, Maaike Bras, Saman Honarnejad, Yang Jiang, Viola Borgdroff, Heribert Bohlen, Arie Reijerkerk, Helma Rutjes, Stefan Braam, Greg Luermanc
, Ncardia, Leiden, The Netherlands bPivot Park Screening Centre, Oss, The Netherlands cNcardia Inc., Plymouth Meeting, PA, United States of America Available online 17 October 2019.

Recent publications

Label-free Mass Spectrometry ultra-High Throughput Screening

Label-free Mass Spectrometry ultra-HighThroughput Screening

Fully automated label-free Mass Spectrometry ultra-High Throughput Screening

INFOGRAPHIC: Label free mass spec uHTS

Is you assay amendable to uHTS? Seven aspects to assess

Is your assay amendable to ultra-High-Throughput Screening? Seven aspects to consider…

Five reasons to outsource a screen at Pivot Park Screening Centre

Five reasons for a startup to outsource a screen to PPSC

Hit Discovery for Public Target Programs in the European Lead Factory: Experiences and Output from Assay Development and Ultra-High-Throughput Screening

Customers & Partners

Can we help you to accelerate
your drug discovery?

Contact

+31 (0) 412 846050 info@ppscreeningcentre.com

Subscribe to our newsletter

Location

Pivot Park – Banting Building (RE2423)
Kloosterstraat 9
5349 AB Oss
The Netherlands

Shipping address

Pivot Park Screening Centre
Building OP
Kloosterstraat 9
5349 AB Oss
The Netherlands

Disclaimer | Privacy Policy